• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant

Tandem t:slim X2 Pump Now Compatible with Dexcom G7 in Canada

by Jasmine Pennic 12/10/2024 Leave a Comment

Tandem t:slim X2 Pump Now Compatible with Dexcom G7 in Canada

What You Should Know:  - Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.  - In-warranty users can now integrate their pumps with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems, providing greater flexibility and choice for diabetes management. - The expanded compatibility with Dexcom G6 and G7 further enhances the pump's capabilities and provides users with greater
Read More

Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland

by Jasmine Pennic 11/18/2024 Leave a Comment

Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland

What You Should Know:  - Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.  - Abbott's FreeStyle Libre portfolio is the world's leading continuous glucose monitoring system, helping more than 6 million people with diabetes across over 60 countries.  Boosting Irish Economy and Manufacturing Capabilities The Kilkenny facility is part of a €440 million
Read More

Abbott’s FreeStyle Libre CGM Systems Now Cleared for Use During Imaging Procedures

by Jasmine Pennic 10/30/2024 Leave a Comment

Abbott's FreeStyle Libre CGM Systems Now Cleared for Use During Imaging Procedures

What You Should Know:  - Abbott  announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.  - The development makes Abbott's systems the first and only patient-applied CGM sensors approved for use during these screenings, offering greater convenience and potential cost savings for people with diabetes. Improving Diabetes
Read More

Glooko Secures $100M, Appoints Mike Alvarez as New CEO

by Fred Pennic 10/10/2024 Leave a Comment

Glooko Secures $100 Million Series F Financing and Appoints Mike Alvarez as Chief Executive Officer

- Glooko, a global digital health company, has announced a successful Series F funding round, raising $100M to fuel its continued growth and product development led by Georgian, with participation from Health Catalyst Capital, Canaan, and other investors.  - In addition to this significant investment, Glooko also announced the appointment of Mike Alvarez as its new Chief Executive Officer. Funding to Drive Product Innovation and Global Expansion This substantial investment will support
Read More

Study: Twin Health Treats Hypertension in Patients with Type 2 Diabetes

by Jasmine Pennic 10/09/2024 Leave a Comment

Twin Health Treats Hypertension in Patients with Type 2 Diabetes

What You Should Know:  - Twin Health, a company known for its Digital Twin™ AI platform that helps individuals achieve remission of type 2 diabetes, has announced promising results in a new study focused on hypertension.  - Published in the Journal of the American College of Cardiology, the study demonstrates that the platform can effectively help users control blood pressure and reduce their reliance on medication. Addressing the Link Between Diabetes and Hypertension High
Read More

Ascensia Launches World’s First One-Year CGM System, Eversense® 365

by Jasmine Pennic 10/02/2024 Leave a Comment

Ascensia Launches World's First One-Year CGM System, Eversense® 365

What You Should Know:  - Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.  - Developed by Senseonics Holdings, Inc., Eversense 365 is the world's first and only CGM system to offer an entire year of continuous glucose monitoring with a single sensor. This innovative technology received FDA clearance last month for individuals with type 1 and type 2 diabetes aged 18 years
Read More

Dexcom and Beyond Type 2 Launch National Glucose Awareness Week with Retta

by Jasmine Pennic 09/23/2024 Leave a Comment

Dexcom and Beyond Type 2 Launch National Glucose Awareness Week with Retta

What You Should Know:  - DexCom, Inc., the global leader in real-time continuous glucose monitoring, and Beyond Type 2, a non-profit organization, are joining forces with actress Retta to launch the first-ever National Glucose Awareness Week.  - Taking place from September 23-29, 2024, this initiative aims to bridge the knowledge gap surrounding glucose health and empower individuals to take control of their well-being. Addressing the Glucose Knowledge Gap While glucose
Read More

ECHO Model Proven Effective for Improving Diabetes Care in Rural Areas

by Jasmine Pennic 09/20/2024 Leave a Comment

Rural Healthcare

- A recent study has shed light on the significant potential of the ECHO Model in improving diabetes care in rural communities.  - The research, published in The Journal of General Internal Medicine, showed that rural healthcare providers participating in weekly ECHO telementoring sessions achieved comparable results to endocrinology specialists in academic medical centers when managing patients with diabetes. Significant Reduction in A1c Levels The study, which spanned five years
Read More

CGMs Through Medical Benefits: Improved Adherence and Cost Savings for Diabetes Patients, New Research Shows

by Jasmine Pennic 09/18/2024 Leave a Comment

FDA Clears Eversense® 365: The World's First One-Year CGM System

What You Should Know:  - A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared to those accessing them through pharmacy benefits.  - The JMIR Diabetes research — Exploring Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients with Diabetes: Impact of Device Sourcing, highlights
Read More

FDA Clears Eversense® 365: The World’s First One-Year CGM System

by Jasmine Pennic 09/18/2024 Leave a Comment

FDA Clears Eversense® 365: The World's First One-Year CGM System

What You Should Know:  - Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.  - This marks a significant advancement in diabetes management, offering a fully-implantable, long-term continuous glucose monitoring (CGM) solution for individuals with Type 1 and Type 2 diabetes aged 18 and older. Eversense 365: Uninterrupted Living with Diabetes Eversense 365 is set to transform the lives of people with diabetes by
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 21
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |